Latest:

Fat Pitch Financials

Special situation stocks and value investing

Stock Quote

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Erasca Inc (NQ: ERAS )

4.350 +0.200 (+4.82%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 3, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,881,884
Open 4.490
Bid (Size) 4.300 (1)
Ask (Size) 4.460 (2)
Prev. Close 4.150
Today's Range 4.250 - 4.570
52wk Range 3.600 - 12.80
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Benzinga's Top Ratings Upgrades, Downgrades For February 3, 2023
 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
 
Via Benzinga

Performance

YTD
+2.11%
+2.11%
1 Month
-2.03%
-2.03%
3 Month
-36.12%
-36.12%
6 Month
-51.45%
-51.45%
1 Year
-60.99%
-60.99%

More News

Read More
Over $4 Million Bet On Werewolf Therapeutics? Check Out These 4 Penny Stocks Insiders Are Buying
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
Erasca to Present at the 41st Annual J.P. Morgan Healthcare Conference
From Erasca, Inc.
Via Globe NewsWire
Red Cat Holdings And 2 Other Penny Stocks Insiders Are Aggressively Buying
Via Benzinga
Erasca Announces First Patient Dosed in HERKULES-1 Phase 1b Trial Evaluating ERAS-007 and ERAS-601 MAPKlamp Combination in RAS/MAPK Pathway-Altered Solid Tumors
From Erasca, Inc.
Via Globe NewsWire
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Erasca Announces FDA Clearance of IND Application for CNS-Penetrant KRAS G12C Inhibitor ERAS-3490 in KRAS G12C-Mutated Advanced or Metastatic Solid Tumors
From Erasca, Inc.
Via Globe NewsWire
RH, HUYA, Bilibili And Some Other Big Stocks Moving Lower On Monday
Via Benzinga
Why Ambrx Biopharma Shares Are Trading Higher By Over 550%? Here Are 52 Stocks Moving In Friday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Lululemon, Li Auto, Hackett Group And Some Other Big Stocks Moving Lower On Friday
Via Benzinga
Erasca Oulicenses Its Mid-Stage Cancer Program To Novartis, Raises $100M Via Equity Offering
Via Benzinga
Erasca Announces Exclusive Worldwide License for Pan-RAF Inhibitor Naporafenib
From Erasca, Inc.
Via Globe NewsWire
Erasca Announces Pricing of Underwritten Offering of Common Stock
From Erasca, Inc.
Via Globe NewsWire
Erasca Announces Clinical Trial Collaboration and Supply Agreement with Pierre Fabre to Evaluate ERAS-007 and Encorafenib Combination
From Erasca, Inc.
Via Globe NewsWire
Erasca to Present at Upcoming Investor Conferences
From Erasca, Inc.
Via Globe NewsWire
Erasca Reports Third Quarter 2022 Financial Results and Business Updates
From Erasca, Inc.
Via Globe NewsWire
Erasca Announces Clinical Trial Collaboration and Supply Agreement with Pfizer to Evaluate ERAS-007 and Palbociclib Combination
From Erasca, Inc.
Via Globe NewsWire
McCormick, Dave & Buster's Entertainment And Other Big Losers From Thursday
Via Benzinga
Why ShiftPixy Surged Around 177%; Here Are 71 Biggest Movers From Yesterday
Via Benzinga
US Stocks Flat, Crude Oil Rises 2%
Via Benzinga
Peering Into Erasca's Recent Short Interest
Via Benzinga
Why Bilibili Is Trading Lower By Over Around 14%, Here Are 50 Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.